DaVita (DVA) Competitors $138.35 -2.01 (-1.43%) As of 01:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DVA vs. ALGN, DXCM, HQY, MMSI, CAH, COR, EHC, HAE, ITGR, and MCKShould you be buying DaVita stock or one of its competitors? The main competitors of DaVita include Align Technology (ALGN), DexCom (DXCM), HealthEquity (HQY), Merit Medical Systems (MMSI), Cardinal Health (CAH), Cencora (COR), Encompass Health (EHC), Haemonetics (HAE), Integer (ITGR), and McKesson (MCK). These companies are all part of the "medical" sector. DaVita vs. Its Competitors Align Technology DexCom HealthEquity Merit Medical Systems Cardinal Health Cencora Encompass Health Haemonetics Integer McKesson DaVita (NYSE:DVA) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, risk, institutional ownership and media sentiment. Which has more risk & volatility, DVA or ALGN? DaVita has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Does the media refer more to DVA or ALGN? In the previous week, Align Technology had 10 more articles in the media than DaVita. MarketBeat recorded 28 mentions for Align Technology and 18 mentions for DaVita. DaVita's average media sentiment score of 1.20 beat Align Technology's score of 0.74 indicating that DaVita is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DaVita 11 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 13 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 3 Negative mention(s) 4 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of DVA or ALGN? 90.1% of DaVita shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 1.5% of DaVita shares are owned by insiders. Comparatively, 0.7% of Align Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has preferable valuation & earnings, DVA or ALGN? DaVita has higher revenue and earnings than Align Technology. DaVita is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDaVita$12.82B0.77$936.34M$10.1713.60Align Technology$4.00B2.63$421.36M$5.9324.50 Is DVA or ALGN more profitable? Align Technology has a net margin of 11.04% compared to DaVita's net margin of 6.35%. DaVita's return on equity of 369.39% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets DaVita6.35% 369.39% 4.62% Align Technology 11.04%13.36%8.32% Do analysts prefer DVA or ALGN? DaVita presently has a consensus target price of $164.00, suggesting a potential upside of 18.54%. Align Technology has a consensus target price of $215.00, suggesting a potential upside of 48.01%. Given Align Technology's stronger consensus rating and higher probable upside, analysts plainly believe Align Technology is more favorable than DaVita.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DaVita 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Align Technology 1 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.60 SummaryAlign Technology beats DaVita on 10 of the 17 factors compared between the two stocks. Get DaVita News Delivered to You Automatically Sign up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DVA vs. The Competition Export to ExcelMetricDaVitaMED IndustryMedical SectorNYSE ExchangeMarket Cap$9.89B$4.08B$5.77B$21.15BDividend YieldN/A1.25%4.40%3.55%P/E Ratio13.6026.7730.3328.97Price / Sales0.77194.10469.8853.05Price / Cash7.3327.2125.7818.23Price / Book28.644.629.494.70Net Income$936.34M$189.47M$3.27B$995.89M7 Day Performance3.72%2.63%2.53%2.18%1 Month Performance-4.61%15.35%4.05%1.98%1 Year Performance-10.16%16.67%30.79%10.48% DaVita Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DVADaVita4.4807 of 5 stars$138.35-1.4%$164.00+18.5%-8.9%$9.89B$12.82B13.6076,000Positive NewsAnalyst UpgradeALGNAlign Technology4.9458 of 5 stars$144.94+1.8%$215.00+48.3%-36.1%$10.51B$4.00B24.4420,945Positive NewsDXCMDexCom4.9616 of 5 stars$80.82-0.2%$99.89+23.6%+11.1%$31.69B$4.03B56.1310,300Positive NewsHQYHealthEquity4.3707 of 5 stars$89.53-0.4%$118.55+32.4%+17.2%$7.74B$1.20B65.353,120News CoveragePositive NewsMMSIMerit Medical Systems4.496 of 5 stars$86.16+0.8%$107.00+24.2%-4.1%$5.10B$1.36B43.747,400News CoveragePositive NewsAnalyst RevisionCAHCardinal Health4.9744 of 5 stars$149.70+0.1%$163.20+9.0%+35.3%$35.75B$222.58B23.2157,700Insider TradeCORCencora4.3825 of 5 stars$290.45-0.8%$311.25+7.2%+22.9%$56.31B$293.96B29.8846,000Positive NewsEHCEncompass Health4.8547 of 5 stars$120.26-0.1%$134.00+11.4%+34.2%$12.11B$5.37B23.5340,000Positive NewsHAEHaemonetics4.9503 of 5 stars$53.25-0.9%$85.18+60.0%-26.2%$2.57B$1.36B16.283,023Positive NewsHigh Trading VolumeITGRInteger3.9393 of 5 stars$105.61-1.1%$140.25+32.8%-12.7%$3.70B$1.72B46.5211,000Positive NewsMCKMcKesson4.5084 of 5 stars$670.82-0.3%$719.27+7.2%+24.6%$83.44B$359.05B26.7545,000Positive News Related Companies and Tools Related Companies ALGN Competitors DXCM Competitors HQY Competitors MMSI Competitors CAH Competitors COR Competitors EHC Competitors HAE Competitors ITGR Competitors MCK Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DVA) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DaVita Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DaVita With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access